Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study - PubMed (original) (raw)

Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.

Fedirko V, Riboli E, Tjønneland A, Ferrari P, Olsen A, Bueno-de-Mesquita HB, van Duijnhoven FJ, Norat T, Jansen EH, Dahm CC, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Lukanova A, Teucher B, Boeing H, Aleksandrova K, Trichopoulou A, Benetou V, Trichopoulos D, Grioni S, Vineis P, Panico S, Palli D, Tumino R, Siersema PD, Peeters PH, Skeie G, Brustad M, Chirlaque MD, Barricarte A, Ramón Quirós J, Sánchez MJ, Dorronsoro M, Bonet C, Palmqvist R, Hallmans G, Key TJ, Crowe F, Khaw KT, Wareham N, Romieu I, McKay J, Wark PA, Romaguera D, Jenab M. Fedirko V, et al. Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):582-93. doi: 10.1158/1055-9965.EPI-11-1065. Epub 2012 Jan 25. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22278364 Free PMC article.